Financial Performance - The company's net profit attributable to owners was HK$5,257 thousand, compared to a loss of HK$54,042 thousand in the previous year[2] - Total comprehensive expenses for the year amounted to HK$2,985 thousand, a significant improvement from the previous year's HK$52,148 thousand[12] - The company's operating profit for 2023 was HK$11.393 million, compared to a loss of HK$44.366 million in 2022[76] - The company's net profit for 2023 was HK$5.165 million, compared to a loss of HK$52.009 million in 2022[76] - Annual profit (loss) for 2023 was HKD 5,165,000, compared to a loss of HKD 52,009,000 in the previous year[90] - The company's profit attributable to owners for the year ended December 31, 2023, was approximately HKD 5,300,000, compared to a loss of HKD 54,000,000 in 2022, with a net profit margin of 1.0% (2022: loss margin of 10.2%)[114] - Non-controlling interests recorded a loss of HKD 92,000 for the year ended December 31, 2023, compared to a profit of HKD 2,000,000 in 2022[190] Revenue and Sales - Revenue from external customers in the Electronics Manufacturing Services segment was HK$444.171 million in 2023, a decrease from HK$502.606 million in 2022[29] - Total revenue for 2023 was HK$501.999 million, down from HK$529.251 million in 2022[28] - Revenue from the Distribution of Communication Products segment dropped to HK$10.402 million in 2023 from HK$18.489 million in 2022[29] - Revenue from the Real Estate Supply Chain Services and Energy Storage Products segment grew to HK$19.846 million in 2023 from HK$7.388 million in 2022[29] - Sales of goods accounted for HK$493.602 million of revenue in 2023, down from HK$521.750 million in 2022[30] - Revenue from real estate supply chain services increased to HK$8.150 million in 2023 from HK$7.388 million in 2022[30] - The group's revenue from real estate supply chain services and energy storage products reached approximately HKD 19,800,000 in 2023, up from HKD 7,400,000 in 2022[40] - Revenue from securities and other asset investments and other businesses contributed approximately HKD 27,300,000 in 2023, compared to HKD 700,000 in 2022[41] - Revenue from electronic manufacturing services decreased by 11.6% to HKD 444,200,000 in 2023, compared to HKD 502,600,000 in 2022[107] - Revenue from the distribution segment decreased by 43.7% to HKD 10,400,000 in 2023, compared to HKD 18,500,000 in 2022[107] - Total revenue for the year ended December 31, 2023, was approximately HKD 502,000,000, a decrease of HKD 27,300,000 compared to the previous year[127] - The electronic manufacturing services and distribution of communication products contributed revenues of approximately HKD 444,200,000 and HKD 10,400,000, respectively, for the year ended December 31, 2023[128] - Revenue from China (including Hong Kong) increased to 84,928 thousand HKD in 2023 from 57,186 thousand HKD in 2022, representing a growth of approximately 48.5%[139] - Revenue from the United States increased to 122,685 thousand HKD in 2023 from 102,579 thousand HKD in 2022, representing a growth of approximately 19.6%[139] - Revenue from Switzerland decreased to 55,882 thousand HKD in 2023 from 94,436 thousand HKD in 2022, representing a decline of approximately 40.8%[139] - The lending business, a new division, generated revenue of approximately 200,000 HKD in 2023, accounting for 0.04% of total revenue, with an operating loss of 1,100,000 HKD[156] - The real estate supply chain services business contributed approximately 19,800,000 HKD in 2023, up from 7,400,000 HKD in 2022, driven by the launch of ESP business[155] - The company's total revenue for 2023 was 501,999 thousand HKD, a decrease from 529,251 thousand HKD in 2022, representing a decline of approximately 5.1%[139] - Revenue from the electronic manufacturing services division for Customer A increased to 235,380 thousand HKD in 2023 from 234,176 thousand HKD in 2022, while Customer B decreased to 68,880 thousand HKD from 85,418 thousand HKD[158] - Total revenue from major European countries (Switzerland, Belgium, and France) decreased to 174,600 thousand HKD in 2023 from 228,300 thousand HKD in 2022, accounting for 34.8% of the group's revenue (2022: 43.1%)[166] - Revenue from the US market increased to 122,700 thousand HKD in 2023 from 102,600 thousand HKD in 2022, representing 24.4% of the group's revenue (2022: 19.4%)[166] - Revenue from China (including Hong Kong) increased to 84,900 thousand HKD in 2023 from 57,200 thousand HKD in 2022, accounting for 16.9% of the group's revenue (2022: 10.8%)[166] - Total revenue for the year ended December 31, 2023, was HKD 502,000,000, down from HKD 529,300,000 in 2022[178] - Revenue from electronic manufacturing services and communication product distribution decreased from HKD 521,100,000 in 2022 to HKD 454,600,000 in 2023[175] - The decline in electronic manufacturing services revenue was primarily due to reduced business in the European market[183] Assets and Liabilities - Non-current assets decreased to HK$70,487 thousand from HK$123,835 thousand in the previous year[5] - Total assets increased to HK$776,418 thousand from HK$659,233 thousand, with current assets rising to HK$705,931 thousand from HK$535,398 thousand[16] - The company's equity attributable to owners increased to HK$486,663 thousand from HK$359,862 thousand in the previous year[17] - The company's total equity increased to HK$488,725 thousand from HK$362,016 thousand in the previous year[17] - Total current liabilities decreased slightly to HK$272.691 million in 2023 from HK$276.303 million in 2022[27] - Non-current liabilities decreased to HK$15.002 million in 2023 from HK$20.914 million in 2022[27] - Bank and cash balances as of December 31, 2023, were approximately HKD 271,600,000, an increase of HKD 19,400,000 compared to 2022, with 25.9%, 68.1%, and 6.0% denominated in RMB, USD, and HKD, respectively[115] - The company's borrowings as of December 31, 2023, were approximately HKD 4,800,000, consisting of loans from financial institutions (HKD 4,300,000) and an independent third party (HKD 500,000)[116] - The company's trade receivables (net of provisions) increased to 145,309 thousand HKD in 2023 from 115,354 thousand HKD in 2022, representing a growth of approximately 26%[150] - Non-current assets in China (including Hong Kong) decreased to 70,487 thousand HKD in 2023 from 123,835 thousand HKD in 2022[158] - The group's bank and cash balances totaled approximately 271,600 thousand HKD as of December 31, 2023, compared to 252,200 thousand HKD in 2022[164] - The group's current ratio remained at a healthy level of 2.6 times as of December 31, 2023, compared to 1.9 times in 2022[169] - The company holds a contingent liability of USD 2,600,000 (approximately HKD 20,300,000) related to a dispute with a supplier of a sold subsidiary[191] Expenses and Costs - Gross profit increased to HK$136.867 million in 2023 from HK$101.396 million in 2022[28] - Gross profit increased by 35.0% to HKD 136,900,000 in 2023 from HKD 101,400,000 in 2022, with the gross profit margin rising by 8.1% due to reduced costs from automation and lower material costs post-COVID-19[44] - Sales and distribution expenses increased to HKD 38,000,000 in 2023, up from HKD 30,000,000 in 2022, primarily due to an increase in employee costs of HKD 8,300,000[111] - Administrative expenses decreased to HKD 88,800,000 in 2023, down from HKD 105,000,000 in 2022, mainly due to a reduction in employee costs of HKD 8,200,000[112] - Research and development expenses slightly decreased by HKD 1,300,000 to HKD 13,200,000 in 2023, compared to HKD 14,500,000 in 2022[113] - Financing costs decreased to HKD 3,100,000 in 2023, down from HKD 4,100,000 in 2022, primarily due to a reduction in finance lease liabilities[113] - Cost of sales decreased by 14.7% from HKD 427,900,000 in 2022 to HKD 365,100,000 in 2023, driven by lower sales and reduced material costs post-COVID[179] - The company's sales and distribution expenses, administrative expenses, R&D expenditures, and financing costs are detailed but not quantified[180] Impairment and Losses - The group recorded an overall impairment loss of approximately HKD 7,500,000 in 2023, a decrease of HKD 5,000,000 from HKD 12,500,000 in 2022, mainly due to intangible asset impairment losses and trade receivables impairment losses[44] - The company's loan portfolio had an annual interest rate of 10%, with impairment losses on loans and receivables of approximately 700,000 HKD in 2023[157] Foreign Exchange and Risk Management - Exchange differences on translation of foreign operations resulted in a loss of HK$8,150 thousand, compared to HK$139 thousand in the previous year[11] - The group's foreign exchange risk is minimal as most business transactions, assets, and liabilities are denominated in the functional currencies of the relevant group entities (RMB and USD) or USD for entities with HKD as the functional currency[56] Corporate Governance and Compliance - The company adopted new and revised Hong Kong Financial Reporting Standards effective from January 1, 2023, with no significant impact on financial statements[19] - The company has not adopted any new or revised Hong Kong Financial Reporting Standards that have been issued but are not yet effective as of January 1, 2023[135] - The company appointed Ms. Zhang Xiulin as an independent non-executive director and audit committee member to comply with listing rules[187] - The company continues to evaluate compliance with corporate governance codes and will nominate suitable candidates for chairman and CEO roles if necessary[184] Shareholder and Equity Information - The weighted average number of ordinary shares for calculating basic and diluted earnings per share (loss) for the years ended December 31, 2023, and 2022, showed no diluted earnings per share due to the exercise price of share options being higher than the average market price of the shares[38] - The company completed a share consolidation on March 30, 2023, with every 10 shares consolidated into 1 share[64] - The company's share price before the grant of share options on January 28, 2021, was HK$0.35[61] - The company has 1,557,836 share options available for grant as of December 31, 2023[79] - The company changed its name, with the new name registered in the Cayman Islands on September 27, 2023, and confirmed by the Hong Kong Companies Registry on October 13, 2023[80] - The company did not recommend the payment of a dividend for the year ended December 31, 2023 (2022: none)[117] Business Operations and Strategy - The company expects the global economy to face challenges in 2024 due to high interest rates, geopolitical tensions, and military confrontations in Eastern Europe and the Middle East[64] - The company's subsidiary reached a final settlement with a third party in 2017, with a payment of $650,000 (approximately HK$5.1 million), and the group has an outstanding guarantee amount of $650,000 as of December 31, 2023[77] - The company plans to expand its new energy charging and storage equipment production, supply chain services, energy storage system integration, and new energy storage technology businesses to align with China's green development policies[102] - The group's lending business, managed through Be Smart Finance Limited, focused on unsecured loans in 2023 and plans to explore further lending opportunities[165] - The company relies on internally generated cash flows to fund its business operations and capital expenditures[181] Employee and Operational Details - The company employed approximately 930 employees across its operations in Hong Kong, the US, and China as of December 31, 2023[95] - The company has implemented strict credit policies and control measures to mitigate credit risks, including identity verification, repayment capacity assessment, and legal actions to minimize potential credit losses[130] - The company has revised its accounting policy related to long-service payment liabilities following the abolition of the offsetting mechanism, with no significant impact on the financial statements as of December 31, 2022, and December 31, 2023[124] Other Income and Expenses - Loan interest income rose to HK$239,000 in 2023 from HK$89,000 in 2022[30] - Other income increased to 13,100 thousand HKD in 2023 from 9,600 thousand HKD in 2022, primarily due to an increase in bank deposit interest income from 2,700 thousand HKD to 8,900 thousand HKD[168] Trade Receivables and Credit Risk - Trade receivables aged 0 to 90 days increased to HKD 125,406 thousand in 2023 from HKD 96,702 thousand in 2022, while those aged 91 to 180 days rose to HKD 18,436 thousand from HKD 17,704 thousand[39] - The company had 4 active loan accounts as of December 31, 2023, with loans and receivables ranging from 5.1% to 8.3% of total loans and receivables[156] Capital Commitments and Investments - Capital commitments as of December 31, 2023, were approximately HKD 300,000, down from HKD 600,000 in 2022[91]

智通财经APP讯，中国储能科技发展(01143)发布公告，预期集团于截至2023年12月31日止年度取得纯利约不超过600万港元，而集团于2022年同期则取得净亏损约5200万港元。 公告称，未经审核综合纯利的预期增长主要来自集团毛利的增长。毛利增长乃来自电子制造服务分部，原因是相较2022年度，期内，生产自动化带来成本节约及Covid-19疫情危机结束后供应链恢复令材料成本下降。 ...

Revenue Performance - Revenue decreased by approximately HK$53.4 million or 18.9% from approximately HK$281.9 million for the period ended 30 June 2022 to approximately HK$228.5 million for the period ended 30 June 2023[7]. - Revenue from the EMS business decreased by 26.8% to HK$197.8 million (2022: HK$270.1 million), while revenue from the distribution of Communications Products decreased by 4.0% to HK$8.2 million (2022: HK$8.6 million)[9]. - Revenue contributions from major European countries totaled HK$60.7 million, accounting for 26.6% of total turnover, down from 36.2% in 2022[22][24]. - The US market contributed HK$56.3 million in revenue, representing 24.6% of total turnover, an increase from 16.7% in 2022[22][24]. - Revenue generated from European countries in the EMS and Distribution business segment decreased by approximately HK$41.4 million or 40.5% for the period ended 30 June 2023[7]. - Revenue from external customers for the six months ended June 30, 2023, was HK$228,457,000, a decrease of 18.99% compared to HK$281,893,000 for the same period in 2022[182]. Profitability and Financial Performance - The Group's gross profit increased by 11.3% to HK$54.7 million, with a gross profit margin of 23.9%, up from 17.4% in 2022[28][33]. - The profit attributable to owners of the Company was HK$4.8 million for the period ended 30 June 2023, a decrease from HK$13.5 million in 2022, with a net profit margin of -2.1% compared to -4.8% in the previous year[49][54]. - Loss for the period narrowed to HK$3,691,000 compared to a loss of HK$12,824,000 in the previous year, representing a 71.2% improvement[166]. - Basic loss per share improved to 2.98 HK cents from 14.16 HK cents in the prior period[164]. - The Group's consolidated loss before tax for the period was HK$1,352,000, significantly improved from a loss of HK$10,934,000 in the same period last year[185]. Expenses and Cost Management - Selling and distribution expenses were HK$14.9 million, accounting for approximately 6.5% of revenue in 2023, slightly up from 5.2% in 2022[38]. - Administrative expenses decreased to HK$51.1 million, representing 22.4% of revenue in 2023, down from 18.9% in 2022[39]. - Research and development expenditure decreased to approximately HK$6.6 million for the period ended 30 June 2023, down from HK$7.3 million in 2022, primarily due to reduced staff costs[40][45]. Cash Flow and Liquidity - The net cash used in operating activities for the first half of 2023 was HK$94,387,000, a significant decline from the net cash generated of HK$33,419,000 in the same period of 2022[174]. - The company generated net cash from investing activities amounting to HK$23,886,000 in the first half of 2023, compared to HK$160,000 in the same period of 2022[174]. - The net cash generated from financing activities was HK$80,634,000 for the six months ended June 30, 2023, a substantial increase from HK$9,688,000 in the prior year[174]. - As of June 30, 2023, cash and cash equivalents at the end of the period were HK$255,479,000, up from HK$189,996,000 at the end of June 2022, reflecting a 34.5% increase[174]. Investment and Capital Expenditure - The Group's capital expenditure amounted to approximately HK$0.8 million, primarily related to the acquisition of plant and machinery for EMS operations[69][73]. - Approximately HK$34.2 million was utilized for the expansion of the Group's product range under the EMS and Distribution Products Businesses, while HK$17.1 million for potential merger and acquisition opportunities remains unutilized as of the report date[96]. Share Capital and Corporate Governance - The total number of issued shares of the Company as of 30 June 2023 was 172,529,185, with a nominal value of HK$0.2 each, following a share consolidation effective on 30 March 2023[58][67]. - The Company completed a subscription of 517,600,000 new shares at a price of HK$0.1855 per share, totaling HK$96,014,800, which represents approximately 42.9% of the existing issued share capital[59][62]. - The Company has complied with the Corporate Governance Code throughout the six months ended 30 June 2023, except for the deviation from code provision C.2.1[104]. - The Board currently comprises seven members, including five executive Directors and two independent non-executive Directors, which is less than the required three independent non-executive Directors[109]. Future Outlook and Strategic Plans - The Group anticipates a positive outlook for the second half of 2023, focusing on steady cash flow from the EMS and Distribution of Communication Products segment[100]. - The Group plans to explore further potential money lending business opportunities while maintaining effective controls and procedures for loan approvals and credit monitoring[16]. - The Group's management is optimistic about the recovery of the global economy and aims to meet the expectations of investors in the market[100]. - The Group continues to focus on its core segments while exploring opportunities for market expansion and new product development[188].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容 概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對 因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 Link-Asia International MedTech Group Limited 環 亞 國 際 醫 療 科 技 集 團 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：1143） 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 的 中 期 業 績 公 告 環亞國際醫療科技集團有限公司（「本公司」）董事（「董事」）會（「董事會」）欣 然 宣 佈，本 公 司 及 其 附 屬 公 司（統 稱「本 集 團」）截 至 二 零 二 三 年 六 月 三 十 日止六個月未經審核綜合中期業績。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 Link-Asia International MedTech Group Limited 環 亞 國 際 醫 療 科 技 集 團 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：1143） 有關截至二零二二年十二月三十一日止年度之 年報之補充公告 茲提述環亞國際醫療科技集團有限公司（「本公司」，連同其附屬公司統稱「本集 團」）於二零二三年四月二十八日刊發的截至二零二二年十二月三十一日止年度之 年報（「二零二二年年報」）。除文義另有所指外，本公告所用詞彙與二零二二年年 報所界定者具有相同涵義。 籌款 除二零二二年年報所提供資料外，本公司謹此向本公司股東及潛在投資者提供以 下有關以下籌款活動所得款項用途的補充資料： 於二零二一年六月三十日完成的配售事項的所得款項用途 於二零二二年年報，本公司於第23頁披露，配售事項（於二零二一年六月三十日 完成）的餘下未動用所得款項淨額約4,010,000港 ...

Fundraising Activities - The company issued 517,600,000 new shares at a subscription price of approximately HK$0.1855 per share, raising a total of HK$96,014,800[1]. - All conditions precedent under the subscription agreement were fulfilled, and the completion took place on February 6, 2023[4]. - The intended use of net proceeds from the fund-raising activities included approximately HK$18 million for existing electronic products and related supply chain services[6]. - The actual use of net proceeds for developing the Group's assisted reproduction medical technology business was approximately HK$5.9 million[8]. - The company has raised approximately HK$29.2 million for general working capital through share placements[8]. - The remaining unutilized net proceeds as of December 31, 2022, are estimated to be HK$21.2 million, expected to be fully utilized in 2023[16]. Financial Performance - Revenue for 2022 decreased to HK$529.3 million, down 21.6% from HK$675.5 million in 2021[114]. - Loss for the year was HK$52.0 million, compared to a loss of HK$47.1 million in 2021[114]. - Revenue from the EMS and Distribution business segment decreased by approximately HK$120.5 million, or 34.6%, for the year ended December 31, 2022[12]. - The Group recorded overall impairment losses of approximately HK$12.5 million for the year ended 31 December 2022, a slight decrease from HK$12.6 million in 2021[157]. - The Group's loss attributable to owners of the Company was approximately HK$54.0 million for the year ended 31 December 2022, with a net loss margin of approximately 10.2%[159]. Revenue Breakdown - Revenue from the EMS and Distribution business segment decreased by approximately HK$120.5 million or 34.6% due to reliance on major customers from Western countries[130]. - Revenue from the Real Estate Supply Chain Services increased by approximately HK$2.8 million or 60.5% as a result of favorable government policies aimed at boosting the real estate market[130]. - Revenue from major European countries totaled approximately HK$228.3 million, accounting for 43.1% of the Group's revenue, a decrease from 51.6% in 2021[155]. - The U.S. market contributed approximately HK$102.6 million in revenue, representing 19.4% of the Group's total revenue, an increase from 12.1% in 2021[155]. Cost and Expenses - Cost of sales decreased by 19.4% from HK$530.6 million in 2021 to HK$427.9 million in 2022, primarily due to a decrease in sales volume and a significant increase in material costs[157]. - Gross profit decreased by 30.0% from HK$144.9 million to HK$101.4 million, with a gross profit margin decline of 2.2% attributed to rising material prices and reduced sales[157]. - Administration expenses decreased to HK$105.0 million in 2022 from HK$154.2 million in 2021, representing approximately 19.8% of the Group's revenue[157]. - Selling and distribution expenses were HK$30.0 million in 2022, accounting for approximately 5.7% of the Group's revenue, compared to 4.3% in 2021[157]. Corporate Governance - The Company is committed to maintaining high standards of corporate governance to protect shareholder interests[22]. - The new Corporate Governance Code came into effect on January 1, 2022, applicable to the financial year starting on that date[23]. - The Company has complied with the Corporate Governance Code throughout the year ended December 31, 2021, with a noted deviation regarding the separation of roles of chairman and chief executive officer[24]. - The board consists of five executive directors and three independent non-executive directors, with the latter accounting for more than one-third of the board[33]. - All independent non-executive directors confirmed their independence as per Rule 3.13 of the Listing Rules[46]. Risk Management - The company remains vigilant in maintaining effective controls and procedures for loan approvals and credit monitoring[13]. - The Group has established strict credit policies and controls to mitigate credit risks associated with its lending operations[150]. - Management regularly reviews groupings of debtors to ensure they share similar credit risk characteristics[151]. Market Conditions - The company has experienced increased costs in transportation of raw materials and finished products due to geopolitical tensions[12]. - The geopolitical situation, particularly the ongoing war in Ukraine, has further complicated the economic landscape, impacting investor confidence and operational costs[130]. - The management anticipates a recovery in the global economy following the end of the three-year epidemic, with activities in retail, project investment, and business meetings returning to normal[17]. Employee and Share Options - As of December 31, 2022, the Group employed approximately 1,025 employees across various operating units in Hong Kong, the U.S.A., and the PRC[173]. - The Group's share options outstanding as of December 31, 2022, include 5,333,092 options for executive directors and 20,316,607 options for employees[172]. - A total of 53,328,000 share options were granted during the year ended December 31, 2022, with all of them lapsed or cancelled by the end of the year[172].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Link-Asia International MedTech Group Limited 環 亞 國 際 醫 療 科 技 集 團 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：1143） 有關截至二零二二年十二月三十一日止年度之 經審核年度業績公告之 補充公告 茲提述環亞國際醫療科技集團有限公司（「本公司」）日期為二零二三年三月三十一 日之公告，內容有關截至二零二二年十二月三十一日止年度之年度業績公告（「業 績公告」）。除文義另有所指外，本公告所用詞彙與業績公告所界定者具有相同涵 義。 除業績公告提供之資料外，董事會謹此提供有關截至二零二二年十二月三十一日 止年度購買、出售或贖回本公司上市證券之進一步資料。 購買、出售或贖回上市證券 截至二零二二年十二月三十一日止年度，本公司或任何附屬公司概無購買、出售 或贖回本公司之上市證券。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容 概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對 因本公告全部或任何部份內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 Link-Asia International MedTech Group Limited 環 亞 國 際 醫 療 科 技 集 團 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：1143） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 之 經 審 核 年 度 業 績 公 告 環亞國際醫療科技集團有限公司（「本公司」）董事會（「董事會」）宣佈本公司 及其附屬公司（「本集團」）截至二零二二年十二月三十一日止年度之經審 核綜合業績及截至二零二一年十二月三十一日止年度的比較數字如下： 綜合損益及其他全面收益表 截至二零二二年十二月三十一日止年度 二零二二年 二零二一年 附註 千港元 千港元 收入 4 529,251 675,523 ...

Financial Performance - For the six months ended June 30, 2022, the Group recorded total revenue of HK$281.9 million, a decrease of approximately 13.2% from HK$324.8 million for the same period in 2021[23]. - The revenue from the EMS business decreased by 9.4% to HK$270.1 million, while revenue from the Distribution of Communications Products business decreased by 64.0% to HK$8.6 million[18]. - Gross profit decreased by approximately 30.4% from HK$70.6 million for the six months ended June 30, 2021, to approximately HK$49.1 million for the same period in 2022[23]. - The loss attributable to owners of the Company was approximately HK$13.5 million for the period ended June 30, 2022, improving from a loss of HK$32.0 million in 2021[30]. - The company reported a loss for the period of HK$12,824,000, compared to a loss of HK$32,129,000 in the previous year, indicating an improvement[85]. - Total comprehensive income for the period was a loss of HK$10,263,000, compared to a loss of HK$29,113,000 in the previous year, indicating a 65% improvement[89]. Revenue Breakdown - Revenue contributions from major European countries totaled approximately HK$131.1 million, accounting for 46.5% of the Group's total turnover for the six months ended June 30, 2022[22]. - The United States market contributed approximately HK$47.1 million in revenue, accounting for 16.7% of total revenue[22]. - The People's Republic of China, including Hong Kong, accounted for approximately HK$26.8 million in revenue[22]. - For the six months ended June 30, 2022, total revenue from external customers was HK$281,893,000, with the electronic manufacturing services segment contributing HK$270,054,000[158]. Cost and Expenses - The increase in material cost price levels due to supply chain chaos and trade disputes between China and the USA contributed to the gross profit decline[23]. - Administrative expenses decreased to HK$53,396,000 from HK$71,696,000, reflecting cost control measures[85]. - The cost of goods sold for the period was HK$231,476,000, compared to HK$251,909,000 in the previous year[192]. - Employee benefits expense, including directors' emoluments, totaled HK$87,200,000 for the six months ended June 30, 2022, down from HK$95,787,000 in the same period of 2021[192]. Cash Flow and Liquidity - As of June 30, 2022, the Group maintained bank and cash balances totaling approximately HK$190.0 million, up from HK$145.6 million as of December 31, 2021[18]. - The company's cash and bank balances rose to HK$189,996,000, up from HK$145,574,000, marking an increase of approximately 30%[91]. - For the six months ended June 30, 2022, the net cash generated from operating activities was HK$33,419,000, compared to a net cash used of HK$19,969,000 in the same period of 2021[102]. Shareholder Information - As of June 30, 2022, the total number of issued shares is 1,207,691,855, an increase from 924,363,855 shares as of December 31, 2021[35]. - The Group has 30,982,791 outstanding share options under the New Share Option Scheme as of June 30, 2022[54]. - The Company has not recommended the payment of an interim dividend for the period, consistent with the previous year (2021: nil)[59]. Governance and Compliance - The Company has complied with the Corporate Governance Code provisions throughout the six months ended 30 June 2022, except for the deviation regarding the roles of chairman and chief executive officer[58]. - The Audit Committee, consisting of three independent non-executive Directors, has reviewed the accounting principles and unaudited condensed consolidated interim financial statements for the six months ended 30 June 2022[59]. - The Company has made specific inquiries to all Directors regarding compliance with the Model Code for Securities Transactions, and all confirmed adherence throughout the reporting period[58]. Future Outlook and Strategy - The Group's management is focused on developing existing core businesses and exploring new business opportunities to maintain a strong financial position amid an uncertain global economic environment[18]. - The Group plans to focus on the high-end medical and health service business in the coming years, while remaining cautious due to the uncertain economic environment caused by COVID-19 variants[54]. - The Group's future strategy includes a focus on the EMS and Distribution of Communication Products segment to ensure stable cash flow[54]. Segment Performance - The segment profit for electronic manufacturing services was HK$6,331,000, while the communications products segment reported a profit of HK$3,456,000[158]. - The total segment assets as of June 30, 2022, amounted to HK$671,711,000, with electronic manufacturing services holding HK$463,987,000[158]. - The total loss of reportable segments for the six months ended June 30, 2022, was HK$9,295,000, a significant improvement from a loss of HK$28,172,000 in the same period of 2021[167].

Financial Performance - The Group's revenue for the year ended December 31, 2021, was approximately HK$675.5 million, an increase from HK$595.0 million in 2020, representing a growth of 13.9%[9] - The revenue from the EMS segment increased to approximately HK$630.0 million, while the revenue from the Distribution of Communication Products businesses slightly increased to approximately HK$40.3 million during the same period[22] - The loss for the year was HK$47.1 million, a significant improvement compared to a loss of HK$173.1 million in 2020, indicating a reduction in loss by 72.8%[9] - Loss per share improved to HK$7.794 from HK$46.119 in the previous year, reflecting a substantial decrease in per-share loss[9] - Total assets increased to HK$678.0 million from HK$657.4 million, while total liabilities decreased to HK$312.0 million from HK$361.5 million, showing a healthier financial position[9] - The Group's total revenue for the year ended December 31, 2021, was approximately HK$675.5 million, an increase of approximately HK$80.5 million from HK$595.0 million in 2020, representing a growth of about 13.5%[39] - Revenue from the electronic manufacturing services segment increased to approximately HK$630 million for the year ended December 31, 2021[24] - Revenue from the distribution of communication products business slightly increased to approximately HK$40.3 million for the year ended December 31, 2021[24] - The Group's revenue growth rate for the EMS and Distribution of Communication Products segments was approximately 15.5%[40] - Revenue from the Real Estate Supply Chain Services business was approximately HK$4.6 million in 2021, down from HK$14.2 million in 2020, significantly impacted by COVID-19 border controls[44] - Cost of sales increased by approximately 20.5% from HK$440.3 million in 2020 to HK$530.6 million in 2021, in line with revenue growth[49] - Gross profit decreased by approximately 6.3% from HK$154.7 million in 2020 to HK$144.9 million in 2021, due to lower gross profit margins in the EMS and Distribution of Communication Products segments[49] Operational Efficiency - Average inventory turnover days were 72.8 days, slightly up from 71.5 days in 2020, indicating stable inventory management[9] - Average trade receivable turnover days improved to 88.5 days from 90.9 days, suggesting better collection efficiency[9] - Selling and distribution expenses were approximately HK$29.2 million for the year ended 31 December 2021, accounting for about 4.3% of the Group's revenue, down from 9.5% in 2020[53] - Administrative expenses amounted to approximately HK$154.2 million, representing 22.8% of revenue for the year ended 31 December 2021, compared to 29.9% in 2020[53] - Research and development expenditure increased slightly to approximately HK$15.0 million for the year ended 31 December 2021, up from HK$13.9 million in 2020[53] Market Challenges and Opportunities - The Group faced challenges in the real estate supply chain services due to epidemic prevention policies, which affected revenue expectations[22] - The overall economic recovery in China contributed positively to the Group's performance, as it was the only major economy to achieve positive growth in the previous year[22] - The Group is exploring the assisted reproductive market through mergers and acquisitions, investment, and joint venture cooperation due to the liberalization of China's fertility policies[39] - The Group has signed cooperation agreements with assisted reproductive medical experts and institutions to reserve assisted reproductive medical technology[29] - The Group aims to implement projects that integrate electronic business and medical business to enhance operational efficiency[39] - The company is optimistic about the high-end medical and health service business due to China's liberalization of fertility policies[134] - The ongoing COVID-19 pandemic is expected to have long-term effects on global supply chains and economic conditions, influencing the company's strategic decisions[134] - The company plans to resume its entry into the Real Estate Supply Chain Services business to meet the housing demand of young homebuyers in Southeast Asia[135] Financial Position and Cash Flow - As of December 31, 2021, the Group had bank and cash balances totaling approximately HK$145.6 million, down from HK$167.7 million in 2020[39] - The Group's current ratio improved to 2.0 times as of 31 December 2021, compared to 1.5 times in 2020[56] - Approximately HK$101.0 million was used in operating activities in 2021, with net cash generated from investing activities at approximately HK$3.5 million and financing activities at approximately HK$74.6 million[60] - In 2021, cash used in operating activities was approximately HK$101 million[61] - Capital expenditure for 2021 amounted to approximately HK$22.1 million, primarily for the acquisition of plant and machinery[65][66] - As of December 31, 2021, capital commitments were approximately HK$0.4 million[66] - The Group held listed equity investments of approximately HK$1.2 million as of December 31, 2021, with no dividend income received during 2020 and 2021[69] Corporate Governance - The company has adopted a new corporate governance code effective from January 1, 2022, which applies to the fiscal year starting from that date[149] - The company has complied with the corporate governance code provisions except for a deviation from provision A.2.1 regarding the separation of the roles of chairman and chief executive officer[149] - The board currently consists of four executive directors and three independent non-executive directors, with the latter accounting for more than one-third of the board[157] - The board's primary duty is to ensure the company's viability and manage it in the best interests of shareholders while considering other stakeholders[164] - The company has established internal guidelines for matters requiring board approval, including strategic plans and major investments[164] - The Board is responsible for ensuring the company's sustainability and managing it in the best interests of shareholders while considering other stakeholders[165] - The Audit Committee was established on December 31, 2010, and as of December 31, 2021, it comprised three independent non-executive Directors[192] - The primary duties of the Audit Committee include reviewing and supervising the financial reporting process and internal control system of the Group[196] Risk Management - The Group's financial condition and business prospects may be affected by various risks and uncertainties, including market, foreign exchange, interest rate, and liquidity risks[115] - The Group's liquidity risk management involves monitoring cash flows and maintaining an adequate level of cash and cash equivalents to meet obligations[121] - The Group's operational risk management is guided by standard operating procedures and regular assessments of key operational exposures[126] - The Group considers managing interest rate risk through various cost-effective means when appropriate[120] - The Group has not identified any significant non-compliance with applicable laws and regulations during the year[109] Share Issuance and Proceeds - The company successfully placed 85,580,000 shares at HK$0.35 per share, generating net proceeds of approximately HK$29.2 million[131] - A subsequent placement of 102,704,000 shares at HK$0.224 per share resulted in net proceeds of approximately HK$22.2 million[131] - On November 23, 2021, the company issued 308,121,285 rights shares at HK$0.2 per share, receiving net cash proceeds of approximately HK$58.7 million[132] - The intended use of the net proceeds from the Rights Issue includes approximately HK$34.2 million for expanding the Group's product range under EMS and Distribution Products, HK$17.1 million for potential merger and acquisition opportunities, and HK$7.4 million for general corporate and working capital[97] - The remaining unutilized net proceeds of approximately HK$29.9 million is estimated to be fully utilized before December 31, 2022[108]